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Abstract
Objectives: Systemic sclerosis (SSc) is characterised by tissue fibrosis of the major organs of the body including the
skin, lungs and heart. We have previously reported that the lncRNA HOTAIR plays a central role in the activation of
SSc myofibroblasts, the key cellular elements of fibrosis. HOTAIR induces fibroblast activation through H3K27me3-
mediated activation of the Notch signalling pathway. Here we aimed to identify the signalling events downstream
of Notch that drive SSc myofibroblast activation.
Methods: Patient fibroblasts were obtained from full-thickness forearm skin biopsies of 3 adult patients with SSc of
recent onset. The lncRNA HOTAIR was expressed in healthy dermal fibroblasts by lentiviral transduction. Hedgehog
signalling pathway was inhibited with GANT61 and GLI2 siRNA. Gamma secretase inhibitors RO4929097 and DAPT
were used to block Notch signalling. GSK126 was used to inhibit Enhancer of Zeste 2 (EZH2).
Results: Overexpression of HOTAIR in dermal fibroblasts induced the expression of the Hedgehog pathway
transcription factor GLI2. This is mediated by activation of Notch signalling following epigenetic downregulation of
miRNA-34a expression. Inhibition of H3K27 methylation and Notch signalling reduced expression of GLI2 in HOTAIR-
expressing fibroblasts as well as in SSc dermal fibroblasts. Importantly, the inhibition of GLI2 function using GANT61
or siRNA mitigates the pro-fibrotic phenotype induced by HOTAIR.
Conclusions: Our data indicates that GLI2 expression is stably upregulated in SSc myofibroblasts through HOTAIR
and that GLI2 mediates the expression of pro-fibrotic markers downstream of Notch.
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Introduction
Systemic sclerosis (SSc) is an autoimmune condition that
initially presents in the skin of the patient’s hands and
feet, where there is a build-up of extracellular matrix
resulting in skin fibrosis. The disease progresses to the
forearms and legs and in the most severe cases (diffuse
SSc) to the trunk. Beyond skin fibrosis, SSc can cause
tissue fibrosis in the internal organs (lungs, heart and
kidneys). The key role of tissue fibroblasts in the disease
has been well-characterised. A number of signalling
pathways such as Transforming Growth Factor beta
(TGF-β) [1–3], Sonic Hedgehog (Shh) [4–6] and Notch
signalling [7, 8] have been implicated in driving
myofibroblast activation, but their precise role and inter-
play is not fully understood. Epigenetic factors are
known to play a key role in the ability of SSc myofibro-
blasts to maintain their phenotype when explanted from
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tissue [9, 10]. We have recently shown that the long
non-coding RNA HOTAIR, in cooperation with the
polycomb repressor complex 2 (PRC2), drives
H3K27me3 histone methylation and silences miRNA-
34a expression. This leads to increased expression of the
miRNA-34a-target Notch1 which results in increasing
Notch signalling and myofibroblast activation [11].
Notch signalling is an important regulator of cell to
cell communication [12]. Upon ligand binding, the
Notch receptor is cleaved by gamma secretases, which
leads to the release of the Notch intracellular domain
(NID). In turn, NID binds to the transcription factor
CSL [13] and initiates transcription of a number of
downstream transcription factors including Hes1 [14],
which has previously been shown to be upregulated in
SSc patient skin and fibroblasts [7, 11]. Inhibition of
Notch signalling blocks the expression of pro-fibrotic
markers in SSc fibroblasts [7, 11]. The downstream tran-
scription factors that play a role in Notch-mediated SSc
fibroblast activation remain unclear. Here we set out to
investigate the molecular mechanism by which Notch
promotes the pro-fibrotic phenotype of SSc fibroblasts.
Ringuette et al. have shown that activation of Notch in
Müller glia induces GLI2 expression [15, 16]. These find-
ings are consistent with the data showing that inhibition
of Notch signalling in amyotrophic lateral sclerosis leads
to reduced GLI2 levels [17]. GLI2 is the main transcrip-
tional activator in canonical Hedgehog (Hh) signalling
[18]. We and others have shown that GLI1 and GLI2 are
upregulated in SSc skin and fibroblasts [5] and SHH path-
way activation plays an important role in the pathogenesis
of tissue fibrosis both in scleroderma and sclerotic graft
versus host disease (GVHD) [5, 6]. These two lines of evi-
dence led us to hypothesise that the activation of GLI2 ob-
served during skin fibrosis could be at least in part driven
by HOTAIR-induced NOTCH activation.
The Hh pathway is essential for normal embryonic de-
velopment and plays a critical role in adult tissue main-
tenance [19]. Hh family members, such as SHH, initiate
signalling through binding to the receptor Patched 1
(PTCH1) [20]. Receptor binding results in derepression
of Smoothened (SMO) [21], a GPCR that mediates activa-
tion of downstream GLI transcription factors. GLI2 and
GLI3 are constitutively expressed and kept inactive by
phosphorylation-dependent proteasomal processing into
transcriptional repressors [22, 23]. Activation of SMO pre-
vents GLI2 and GLI3 processing and induces accumula-
tion of full-length activators, which initiate transcription
of target genes, among which are GLI1 and PTCH1 [21].
In this study, we show that HOTAIR expression is suf-
ficient to drive Notch-dependent increase of GLI2 ex-
pression through Enhancer of Zeste Homology 2
(EZH2)-dependent repression of miRNA-34a and that
inhibition of GLI2 is sufficient to reduce the pro-fibrotic
phenotype of dermal fibroblasts.
Materials and methods
Patient cell lines
Full-thickness skin biopsies were surgically obtained
from the forearms of 3 adult patients with SSc of recent
onset, which was defined as disease duration of less than
18months from the appearance of clinically detectable
skin induration. The patients satisfied the 2013 ACR/
EULAR criteria for the classification of SSc and had the
diffuse cutaneous clinical subset as defined by LeRoy
et al. [24]. Healthy and SSc patient fibroblasts were iso-
lated and established from the biopsies as described [3].
Briefly, isolated healthy and SSc fibroblasts were retrovi-
rally transduced with HTERT to immortalise the fibro-
blasts. Experiments were performed when the fibroblasts
were between passages 3 and 6. All participants provided
written informed consent to participate in this study. In-
formed consent procedure was approved by NRES-
011NE to Dr. Francesco Del Galdo.
Small molecule inhibitors
GSK126 is a EZH2 methylation transferase inhibitor. It
was used at a final concentration of 5 μM and purchased
from LKT Laboratories. The gamma secretase inhibitors
R04929097 (Cayman Chemicals) and DAPT (Tocris)
were used at final concentrations of 1 μM and 10 μM, re-
spectively. The GLI inhibitor GANT61 was used at a final
(See figure on previous page.)
Fig. 1 HOTAIR expression in dermal fibroblasts increases Notch-dependent GLI2 transcription. Dermal fibroblasts were transduced with
lentiviruses containing a scramble or HOTAIR sequence. RNA and protein were extracted from these cells. a GLI2, H3K27m3 and NID protein
levels were assessed by western blot. β-actin was used as a loading control. b Graph represents mean and standard error of densitometry analysis
of GLI2 western blot. c GLI2 transcript levels were analysed. Graphs represent the mean and standard error for three independent experiments.
RNA and protein were extracted from scramble and HOTAIR-expressing fibroblasts. In addition, scramble and HOTAIR-expressing fibroblasts were
treated with the gamma secretase inhibitor R04929097. d GLI2 and NID protein levels were assessed by western blot. β-actin was used as a
loading control. GLI2 (e) and HES1 (f) transcript levels were analysed. Graphs represent the mean and standard error for three independent
experiments. RNA was extracted from healthy and SSc fibroblasts. In addition, healthy and SSc fibroblasts were treated with the gamma secretase
inhibitor R04929097. HES1 (g) and GLI2 (h) transcript levels were analysed. Graphs represent the mean and standard error for three independent
experiments. RNA was extracted from healthy and SSc fibroblasts. In addition, healthy and SSc fibroblasts were treated with the gamma secretase
inhibitor DAPT. HES1 (i) and GLI2 (j) transcript levels were analysed. Graphs represent the mean and standard error for three independent
experiments.*p < 0.05, **p < 0.01, ***p < 0.001
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concentration of 10 μM (Selleck). All inhibitors were
reconstituted in DMSO and added to fibroblasts in
complete media for 48 h at 37 °C in a 5% CO2 atmosphere.
The inhibitor concentrations were selected as they have
been shown to efficiently block their respective pathways
in SSc fibroblasts in previous studies [7, 8, 10, 11].
Lentiviral transduction
Fibroblasts were grown from healthy control forearm bi-
opsies and immortalised using retrovirus expressing
human telomerase (hTERT) as previously outlined [3].
HOTAIR expression was then induced by transduction
with GIPZ lentiviruses carrying HOTAIR gene sequence
or scrambled RNA sequence as control in frame with
puromycin resistance gene and GFP fluorochrome gene
(Open Biosystems, Surrey, UK). For this purpose,
cells were seeded at 50% confluence and infected with
lentiviral particles in serum-free DMEM and incubated
for 6 h, after which an additional 1 ml of DMEM con-
taining 10% FCS was added and the cells were incubated
Fig. 2 HOTAIR suppresses miRNA-34a to enhance Notch-mediated GLI2 expression. RNA was extracted from HOTAIR-expressing fibroblasts
transfected with an miRNA-34a mimic or a scramble miRNA mimic. GLI2 (a), NOTCH1 (b) and miRNA-34a (c) transcript levels were analysed.
Graphs represent the mean and standard error for three independent experiments. RNA was extracted from SSc fibroblasts transfected with
miRNA-34a mimic or a scramble miRNA mimic. GLI2 (d), NOTCH1 (e) and miRNA34a (f) transcript levels were analysed. Graphs represent the mean
and standard error for three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
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for a further 72 h. Stably transduced cells were positively
sorted for GFP fluorescence employing fluorescence-
activated cell sorting in sterile conditions (BD INFLUX).
Positively sorted cells were further selected in media
containing 1.0 μg/ml puromycin (Life Technologies) for
10 days.
miRNA-34a transfections
Fibroblasts were transfected with 67 nM of miRNA-34a
mimic or a negative control scramble miRNA (both
from Qiagen) using Lipofectamine 2000 transfection re-
agent. Fibroblasts were then incubated for 48 h prior to
harvesting.
GLI2 siRNA transfection
A pool of four siRNA duplexes specific for GLI2 (target-
ing different regions of the mRNA) or a negative control
scramble siRNA (both from Qiagen) were transfected
into fibroblasts using Lipofectamine 2000 transfection
reagent. Fibroblasts were then incubated for 48 h prior
to harvesting.
Sonic hedgehog stimulation
Scramble and HOTAIR-expressing fibroblasts were
serum starved for 24 h with DMEM containing 0.5%
FBS, then stimulated with 2 μg/ml SHH ligand (R&D
systems) for a further 24 h.
Immunofluorescence
Fibroblasts were grown on glass coverslips, fixed with
4% paraformaldehyde and permeabilised with 0.1% Tri-
ton X-100 in PBS. Coverslips were stained with a mouse
α-SMA antibody (Abcam ab7817) or acetylated α-
tubulin and visualised with an Alexa 594-conjugated Ab
(Thermo-Life Technologies). The nuclei were counter-
stained with 4′,6-diamidino-2-phenylindole (DAPI) and
mounted in Prolong Gold (Invitrogen). Cilium lengths
were measured using ImageJ software. Thirty cilia were
measured for each experimental condition from 4 inde-
pendent experiments.
Western blotting
Total protein was extracted from fibroblasts in RIPA
buffer and resolved by SDS-PAGE (10–15% Tris-
Glycine), transferred onto Hybond nitrocellulose mem-
brane (Amersham Biosciences) and probed with anti-
bodies specific for alpha smooth muscle actin (α-SMA)
(Abcam ab7817), Notch1 (Cell signalling 3608),
H3K27me3 (Abcam ab6002), β-Actin (Sigma A5441),
GLI1 (Santa Cruz sc-515751) and GLI2 (Novus Biologi-
cals AF3635). Immunoblots were visualised with species-
specific HRP-conjugated secondary antibodies (Sigma)
and ECL (Thermo/Pierce) on a Biorad ChemiDoc im-
aging system.
Quantitative real-time PCR
RNA was extracted from cells using the RNA extraction
kit (Zymo Research) following the manufacturer's proto-
cols. One microgramme of RNA was reverse transcribed
using the cDNA synthesis kit (Thermo). Q-RT-PCR ana-
lysis was performed using the SYBR Green PCR master-
mix kit (Thermo) using the PCR machine (Thermo)
Fig. 3 HOTAIR drives GLI2 transcription through EZH2 in HOTAIR-
expressing and SSc fibroblasts. RNA and protein were extracted from
scramble and HOTAIR-expressing fibroblasts. In addition, the scramble
and HOTAIR-expressing fibroblasts were treated with the EZH2 inhibitor
GSK126. a GLI2 transcript levels were analysed. Graph represents the
mean and standard error for three independent experiments. b GLI2, α-
SMA and NID protein levels were assessed by western blot. β-actin was
used as a loading control. c RNA was extracted from healthy and SSc
fibroblasts. In addition, healthy and SSc fibroblasts were treated with the
EZH2 inhibitors GSK126. GLI2 transcript levels were analysed for both
inhibitors. Graphs represent the mean and standard error for three
independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
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with primers specific for GLI1 (forward GGACCT
GCAGACGGTTATCC, reverse AGCCTCCTGGAGAT
GTGCAT), GLI2 (forward TTTATGGGCATCCTCT
CTGG, reverse TTTTGCATTCCTTCCTGTCC), Ptch1
(forward CGATGGAGTCCTTGCCTACAA, reverse
CCACCAGACGCTGTTTAGTCA), collagen type 1A1
(forward CCTCCAGGGCTCCAACGAG, reverse TCTA
TCACTGTCTTGCCCCA), type 1A2 (forward GATG
TTGAACTTGTTGCTGAGC, reverse TCTTTCCCCA
TTCATTTGTCTT), alpha SMA (forward TGTATGTG
GCTATCCAGGCG, reverse AGAGTCCAGCACGATG
CCAG), CTGF (forward GTGTGCACTGCCAAAGAT




CTTTGGTTTATCC) and GAPDH (forward ACCCACTC
CTCCACCTTTGA, reverse CTGTTGCTGTAGCCAAAT
TCGT). The data obtained was analysed according to the
ΔΔ Ct method. GAPDH served as housekeeping gene.
Statistical analysis
Results were presented as mean and standard error. Stat-
istical analysis was performed using a two-tailed, paired
Student’s t test.
Results
Overexpression of HOTAIR in dermal fibroblasts induces
NOTCH-dependent GLI2 expression
Notch signalling is known to enhance expression of the
transcription factor GLI2 [16, 17], and HOTAIR is known
to regulate Notch expression in fibroblasts [11]. Therefore,
we first investigated whether HOTAIR regulates the expres-
sion of GLI2 in dermal fibroblasts. Dermal fibroblasts over-
expressing HOTAIR were generated as previously described
[11] and showed stable H3K27me3 increased levels, as ex-
pected (Fig. 1a), since HOTAIR exerts a stimulatory func-
tion on the PRC2 complex [25]. As previously shown,
HOTAIR induced an increase in NOTCH signalling as de-
termined by increased levels of the transcriptionally active
NOTCH intracellular domain (NID) (Fig. 1a). HOTAIR
overexpression increased GLI2 expression at both protein
(Fig. 1a, b) and mRNA levels (Fig. 1c) by 6- and 3-fold, re-
spectively (p < 0.05 for both). To determine whether
HOTAIR-mediated GLI2 upregulation was the consequence
of enhanced Notch signalling, we investigated the levels of
GLI2 in the presence of the gamma secretase inhibitor
R04929097. As shown in Fig. 1d and e, R04929097 treat-
ment (1 μM for 48 h) reduced GLI2 expression in
HOTAIR-expressing fibroblasts but did not alter GLI2 levels
in the scramble fibroblasts. We confirmed that R04929097
was effective in inhibiting NOTCH signalling, as we ob-
served reduced levels of NID and reduced transcription of
the HES1 gene, a downstream target of Notch (Fig. 1d, f).
Importantly, SSc patient-derived fibroblasts showed an
increase of HES1 mRNA levels (Fig. 1g), consistent with
previously reported data [11]. HES1 increased expression
was effectively suppressed by R04929097. In this setting,
inhibition of NOTCH signalling reduced the levels of
GLI2 to a level undistinguishable from that of a healthy
control (Fig. 1h), suggesting that upregulation of
NOTCH signalling in SSc drives GLI2 upregulation.
R04929097 did not alter GLI2 levels in the healthy fibro-
blasts (Fig. 1h). To rule out off-target effects of the
gamma secretase inhibitor, we used a second gamma
secretase inhibitor (DAPT) with a different mode of ac-
tion. Consistent with RO4929097, inhibiting Notch sig-
nalling in SSc fibroblasts with DAPT reduced HES1
(Fig. 1i) and GLI2 (Fig. 1j) transcript levels.
Interestingly, HOTAIR-induced GLI2 played no role in
the maintenance of NOTCH1 expression in dermal fibro-
blasts, as we observed no reduction in NOTCH1 expres-
sion in HOTAIR-expressing fibroblasts transfected with
GLI2 siRNA (Suppl. Fig. 1A-B) or treated with the GLI in-
hibitor GANT61 (Suppl. Fig. 1C). Similarly, depletion of
GLI2 in SSc fibroblasts did not affect NOTCH1 levels
(Suppl. Fig. 1D-E).
Upregulation of GLI2 in HOTAIR-expressing fibroblasts is
mediated by miRNA-34a suppression
Previously, we have shown that HOTAIR enhances
NOTCH1 expression through the suppression of
(See figure on previous page.)
Fig. 4 Overexpression of HOTAIR does not induce GLI1 expression and prevents SHH-mediated induction of GLI1. Dermal fibroblasts were
transduced with lentiviruses containing a scramble or HOTAIR sequence. RNA and protein were extracted from these cells. a GLI1 and NID
protein levels were analysed by western blot. β-actin was used as a loading control. GLI1 (b) and PTCH1 (c) transcript levels were analysed. Graphs
represent the mean and standard error for three independent experiments. RNA was extracted from scramble and HOTAIR-expressing fibroblasts.
In addition, the scramble and HOTAIR-expressing fibroblasts were transfected with GLI2 siRNA. A scramble control siRNA was transfected as
control. PTCH1 (d) transcript levels were assessed. Graphs represent the mean and standard error for three independent experiments. e RNA was
extracted from serum depleted scramble and HOTAIR-expressing fibroblasts. In addition scramble and HOTAIR-expressing fibroblasts were
stimulated with SHH ligand for 24 h. GLI1 transcript levels were analysed. Graph represents the mean and standard error for three independent
experiments. f Scramble and HOTAIR-expressing fibroblasts were stained for an antibody specific for acetylated α-tubulin and visualised with an
Alexa 594-conjugated secondary antibody. DAPI was used to visualise the nuclei (blue). The images are individual cells at a magnification of × 63
with a wider field of view in the insert. Graph represents mean cilium lengths from 4 independent experiments where 30 cells were measured.
*p < 0.05, **p < 0.01, ***p < 0.001
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miRNA-34a [11]. Therefore, we hypothesised that
HOTAIR’s ability to suppress miRNA-34a might be
important for GLI2 expression. To test this hypoth-
esis, we transfected a miRNA-34a mimic or a scram-
bled control miRNA in HOTAIR-expressing
fibroblasts. Rescue of miRNA-34a expression reduced
GLI2 and NOTCH1 mRNA levels in HOTAIR-
expressing fibroblasts (Fig. 2a, b). Transfection of the
miRNA-34a mimic in SSc fibroblasts also led to a sig-
nificant reduction in GLI2 expression levels (Fig. 2d).
Mechanistically, miRNA-34a repressed expression of
NOTCH1 transcripts in SSc fibroblasts (Fig. 2e). Of
note, the miRNA-34a mimic transfection resulted in
2–2.5-fold increase in expression over basal both in
HOTAIR- and SSc fibroblasts (Fig. 2c, f), suggesting
that small changes in miRNA-34a are sufficient to
downregulate NOTCH1 and GLI2 expression. Taken
together, these data indicate that HOTAIR stimulates
GLI2 expression through downregulation of miRNA-
34a, which controls NOTCH1.
HOTAIR drives GLI2 expression through epigenetic
changes directed by EZH2
One of the best known roles of lncRNA HOTAIR is the
activation of the polycomb repressor complex (PRC2)
[25]. We therefore investigated whether inhibition of the
PRC2 enzyme EZH2 in HOTAIR-expressing fibroblasts
affected the expression of GLI2. Treatment of HOTAIR-
expressing fibroblasts with the EZH2 inhibitor
GSK126 for 48 h strongly reduced GLI2 transcript
levels, but the inhibitor had no effect on GLI2 levels
in the scramble fibroblasts (Fig. 3a). Consistent with
these findings, we observed a strong reduction in
GLI2 protein (70% reduction in the GSK126-treated
fibroblasts) in the HOTAIR-expressing fibroblasts
treated with the inhibitor (Fig. 3b). We also observed
a reduction in α-SMA and NID levels in the
HOTAIR-expressing fibroblasts treated with GSK126
(Fig. 3b), as previously described [11]. Inhibition of
EZH2 in SSc patient-derived fibroblasts produced
similar results. In SSc fibroblasts, GSK126 treatment
reduced GLI2 mRNA levels by 45% (p < 0.05) (Fig. 3c).
Interestingly, GSK503, a second EZH2 inhibitor that
is structurally similar to GSK126, showed similar re-
sults, suppressing GLI2 mRNA to levels comparable
to dermal fibroblasts derived from healthy control
skin biopsies (data not shown).
Overexpression of HOTAIR leads to aberrant canonical
Hedgehog signalling
GLI2 is the main transcriptional activator of the Hh
pathway. In the absence of Hh ligand stimulation, GLI2
exists in two forms: a full-length low activity activator
and a shorter processed transcriptional repressor. Upon
binding of a Hh ligand to PTCH1, processing is inhib-
ited and full-length GLI2 is phosphorylated at the pri-
mary cilium to maximally increase its transcriptional
activity [21]. GLI2 activation leads to GLI1 induction at
the transcriptional level, as well as upregulation of other
GLI target genes, such as PTCH1. To determine whether
GLI2 upregulation by HOTAIR resulted in activation of
the canonical Hh pathway, we quantified the expression
of GLI1 and PTCH1, the hallmarks of GLI-dependent
transcription. As shown in Fig. 4a and b, expression of
GLI1 at protein and transcript levels was similar in
scramble and HOTAIR-expressing fibroblasts. However,
we observed a 1.6-fold upregulation of PTCH1 mRNA
levels (Fig. 4c) that was prevented by silencing of GLI2
expression (Fig. 4d). Next, we evaluated the effect of
modulators of the EZH2/Notch/miRNA-34a pathway on
GLI1 levels. Consistent with the lack of GLI1 induction
by upregulation of GLI2, we observed no effects of
EZH2 and gamma secretase inhibitors and miRNA-34a
rescue on GLI1 expression in HOTAIR-expressing fibro-
blasts (Fig. S2A) or in SSc fibroblasts (Fig. S2B).
Given that higher levels of GLI2 might confer a
heightened sensitivity of HOTAIR-expressing fibroblasts
to Hh ligands, we investigated their responsiveness to
SHH. We stimulated scramble and HOTAIR-expressing
fibroblasts with 2 μg/ml SHH for 24 h. Unexpectedly,
while scramble cells showed a 6-fold increase in GLI1
expression, HOTAIR-expressing fibroblasts exhibited a
weak response to SHH of about 2-fold (Fig. 4e). We sus-
pected that HOTAIR expression could be altering pri-
mary cilia, essential for canonical SHH signalling [26].
However, HOTAIR did not alter the cilium length or
gross structure, as shown with acetylated α-tubulin
staining (Fig. 4f).
GLI2 is essential for HOTAIR-mediated myofibroblastic
transformation
To determine whether the increase in GLI2 expression
observed in HOTAIR-expressing cells is a mediator of
pro-fibrotic activation, we silenced GLI2 in the
HOTAIR-expressing fibroblasts with siRNA and
(See figure on previous page.)
Fig. 5 GLI2 silencing leads to a reduction in HOTAIR-mediated fibroblast activation. RNA and protein were extracted from scramble and HOTAIR-
expressing fibroblasts. In addition, the scramble and HOTAIR-expressing fibroblasts were transfected with siRNA specific for GLI2. A scramble
control siRNA was transfected into the other cell conditions. a α-SMA and GLI2 protein levels were assessed by western blot. β-actin was used as
a loading control. α-SMA (b), COL1A1 (c), COL1A2 (d) and CTGF (e) transcript levels were assessed by qPCR. Graphs represent the mean and
standard error for three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 6 Inhibition of GLI2 leads to a reduction in HOTAIR-mediated fibroblast activation. RNA and protein were extracted from scramble and
HOTAIR-expressing fibroblasts. In addition, HOTAIR-expressing fibroblasts were treated with the GLI inhibitor GANT61. a α-SMA protein levels were
assessed by western blot. β-actin was used as a loading control. b Graph represents mean and standard error for densitometry analysis of the α-SMA
western blots. c Scramble and HOTAIR-expressing fibroblasts were stained with an antibody specific for α-SMA. In addition, HOTAIR-expressing
fibroblasts were treated with the GANT61. The α-SMA antibody was visualised with a mouse-specific Alexa 594-conjugated secondary antibody. DAPI
was used to visualise the nuclei (blue). Red scale bars represent 20 μm. PTCH1 (d), GLI2 (e), COL1A1(f), COL1A2 (g), α-SMA (h) and CTGF (i) transcript
levels were analysed. Graphs represent the mean and standard error for three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
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assessed pro-fibrotic marker expression. Reduction of
GLI2 mRNA levels in HOTAIR-expressing fibroblasts by
80% reduced the expression of the pro-fibrotic markers
α-SMA, COL1A1, COL1A2 and CTGF (Supp. Figure 1B
and Fig. 5a–e). Depletion of GLI2 in the scramble con-
trol fibroblasts had no effect on pro-fibrotic marker ex-
pression. This suggests that GLI2 is an essential
mediator of fibroblast activation by HOTAIR. In a com-
plementary approach, we treated HOTAIR-expressing fi-
broblasts with the dual GLI1/GLI2 inhibitor GANT61
for 48 h. GANT61 reduced α-SMA protein levels in
HOTAIR-expressing fibroblasts (Fig. 6a–c). GANT61
treatment decreased PTCH1 and GLI2 levels (Fig. 6d, e),
suggesting the inhibitor was functional. In addition, we
observed a reduction in mRNA levels of COL1A1,
COL1A2, α-SMA and CTGF transcript levels in
HOTAIR-expressing fibroblasts treated with the GLI in-
hibitor (Fig. 6f–i).
Downregulation of GLI2 by siRNA depletion or inhib-
ition with GANT61 reduced fibrotic marker expression
levels in SSc fibroblasts (Figs. 7a-d and 8 a-h), as previ-
ously described [27]. Taken together, this data suggests
that HOTAIR ability to regulate GLI2 expression is im-
portant for its capacity to induce pro-fibrotic activation
(Fig. 8l).
Discussion
SHH expression is upregulated in SSc skin and serum
[28], with increased expression of PTCH1 and PTCH2
and the transcription factors GLI1 and GLI2 [5, 6]. It is
Fig. 7 Depletion of GLI2 leads to reduced pro-fibrotic marker expression in SSc fibroblasts. RNA were extracted from healthy and SSc fibroblasts.
In addition, the healthy and SSc fibroblasts were transfected with siRNA specific for GLI2. A scramble control siRNA was transfected into the other
cell conditions. PTCH1 (a) α-SMA (b), COL1A1 (c) and CTGF (d) transcript levels were assessed by qPCR. Graphs represent the mean and standard
error for three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001
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noteworthy, though, that unlike GLI1, GLI2 is not a
transcriptional target of the Hh pathway and its overex-
pression in SSc is putatively attributed to the known
TGF-β/Smad-induced activation of the GLI2 promoter
[27]. Activation of Hh signalling in fibroblasts was
shown to upregulate markers of myofibroblast activation
such as COL1A1, COL2A1 and α-SMA and increased
stress fibre formation [29]. The data in the literature
shows that SSc fibroblasts maintain high levels of GLI2
expression in vitro. This suggests that epigenetic factors
play an important role in this observation. In this study,
we show that the PRC2 complex in cooperation with the
lncRNA HOTAIR drives GLI2 expression in vitro
through their ability to enhance Notch signalling.
The data presented here provides further mechanistic
insight into the ability of HOTAIR to drive the activa-
tion of dermal fibroblasts. Here we show that HOTAIR
drives pro-fibrotic markers in dermal fibroblasts partly
through increased expression of the pro-fibrotic GLI2
protein. This is mediated through the suppression of the
miRNA-34a which releases NOTCH1 suppression and
leads to GLI2 transcription. Questions remain as to
whether NID (in cooperation with the transcription fac-
tor CSL) directly binds to the GLI2 promoter and initi-
ates transcription or there are further intermediates in
the pathway. Additionally, it is not clear whether GLI2
directly initiates the transcription of the pro-fibrotic
markers in SSc fibroblasts. These are interesting ques-
tions that need to be addressed in further studies.
Transcription of GLI2 has been shown to be driven by
TGF-β in SSc [28]. Therefore, HOTAIR/Notch may co-
operate with TGF-β to enhance GLI2 expression. There
is evidence of cooperation between Notch and TGF-β
signalling. Notch signalling is linked to phospho-SMAD
activity [30] and TGF-β stimulation is known to enhance
Hes1 expression through the interaction between Notch
intracellular domain and SMAD3 [31]. In SSc fibroblasts,
HOTAIR may prime the fibroblasts by enhancing Notch
expression and this allows TGF-β to enhance GLI2
expression.
One caveat of this study is HOTAIR enhances GLI2
expression but not GLI1. This is interesting as GLI1 is a
major transcriptional target of GLI2 in the Hh pathway
[21]. Hh signalling primarily initiates at the cilia on the
cell surface. Therefore, it is possible HOTAIR alters the
cilium function in the fibroblasts, therefore altering the
way the fibroblasts respond to SHH. We showed
that HOTAIR does not alter the length of cilia (Fig. 4f)
but it may alter their composition or ultrastructure,
which may prevent the ability of the HOTAIR-
expressing fibroblasts to respond to SHH.
Finally, this study has implications beyond fibrotic
conditions. The Hh pathway is known to be overex-
pressed and deregulated in a number of cancers [32].
There is a new body of evidence that HOTAIR is also
overexpressed in a number of cancers [33, 34], which
suggests that HOTAIR may play a role in SHH dysregu-
lation in cancer. Altogether, the effect of HOTAIR ex-
pression on GLI2 gives an important mechanistic insight
on the profound epigenetic changes driven by PRC2
during fibrosis, which would be amenable of therapeutic
targeting.
Conclusion
We have identified a novel mechanism in which the Hh-
responsive transcription factor GLI2 is upregulated in
SSc fibroblasts. The long non-coding RNA HOTAIR in-
creases GLI2 expression through enhanced Notch sig-
nalling. This provides a greater understanding of
HOTAIR-mediated fibrosis in systemic sclerosis.
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Additional file 1: FigureS1. Inhibition of GLI2 does not affect NOTCH1
expression. RNA was extracted from scramble and HOTAIR-expressing fi-
broblasts. In addition, scramble and HOTAIR expressing fibroblasts were
transfected with siRNA specific for GLI2. A scramble control siRNA was
transfected into the other cell conditions. NOTCH1 (A) and GLI2 (B) tran-
script levels were analysed. Graphs represent the mean and standard
error for three independent experiments. RNA was extracted from scram-
ble and HOTAIR-expressing fibroblasts. In addition, HOTAIR-expressing fi-
broblasts were treated with the GLI inhibitor GANT61. (C)
NOTCH1 transcript levels were analysed. Graphs represent the mean and
standard error for three independent experiments. RNA was extracted
from healthy and SSc fibroblasts. In addition, healthy and SSc fibroblasts
were transfected with siRNA specific for GLI2. A scramble control siRNA
was transfected into the other cell conditions. NOTCH1 (D) and GLI2 (E)
transcript levels were analysed. Graphs represent the mean and standard
error for three independent experiments. *p < 0.05, **p < 0.01, ***p <
0.001. Fig. S2. GLI1 expression in HOTAIR and SSc fibroblasts is insensitive
to EZH2 and gamma secretase inhibitors. (A) RNA was extracted from
HOTAIR expressing fibroblasts. In addition, HOTAIR expressing fibroblasts
were treated with the EZH2 inhibitor GSK126, the gamma secretase in-
hibitor R04929097 and transfected with miRNA-34a mimic. GLI1 transcript
levels were analysed. Graph represents the mean and standard error for
three independent experiments. (B) RNA was extracted from SSc fibro-
blasts. In addition SSc fibroblasts were treated with the EZH2 inhibitor
GSK126, the gamma secretase inhibitor R04929097 and transfected with
(See figure on previous page.)
Fig. 8 GLI2 inhibition reduces pro-fibrotic markers in SSc fibroblasts. RNA and protein were extracted from healthy and SSc fibroblasts. In
addition, SSc fibroblasts were treated with the Gli inhibitor GANT61. a α-SMA protein levels were assessed by western blot. β-actin was used as a
loading control. b Graph represents the mean and standard error for densitometry analysis of the α-SMA western blots. PTCH1 (c), GLI2 (d),
COL1A1 (e), COL1A2 (f), α-SMA (g) and CTGF (h) transcript levels were analysed. Graphs represent the mean and standard error for three
independent experiments. i Schematic of the HOTAIR/EZH2/miRNA-34a/Notch-mediated activation of GLI2. *p < 0.05, **p < 0.01, ***p < 0.001
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miRNA-34a mimic. GLI1 transcript levels were analysed. Graph represents
the mean and standard error for three independent experiments.
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